D012536DisordersC17.800.7384140.975474Scalp Dermatosesprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonDermatologyWake Forest School of MedicineKristenZellerKristen A. Zeller MD36.08959100000000-80.268599000000001178Zeller, KristenAssociate ProfessorJosephJorizzoJoseph L. Jorizzo MD36.08959100000000-80.26859900000000432Jorizzo, JosephProfessorAmyMcMichaelAmy McMichael MD36.08959100000000-80.2685990000000045McMichael, AmyProfessorStevenFeldmanSteven R. Feldman MD, PhD36.08959100000000-80.26859900000000884Feldman, StevenProfessor27617530Hill D, Farhangian ME, Feldman SRDermatology online journalHill D, Farhangian ME, Feldman SR. Increasing adherence to topical therapy in psoriasis through use of solution medication. Dermatol Online J. 2016 May 15; 22(5).Dermatol Online J2016-05-15T00:00:002016Increasing adherence to topical therapy in psoriasis through use of solution medication.28873105Taylor SC, Barbosa V, Burgess C, Heath C, McMichael AJ, Ogunleye T, Callender VCutisTaylor SC, Barbosa V, Burgess C, Heath C, McMichael AJ, Ogunleye T, Callender V. Hair and scalp disorders in adult and pediatric patients with skin of color. Cutis. 2017 Jul; 100(1):31-35.Cutis2017-07-01T00:00:002017Hair and scalp disorders in adult and pediatric patients with skin of color.30946098Arnold D, Hoffman MB, Onajin O, Sangüeza OP, McMichael AThe American Journal of dermatopathologyArnold D, Hoffman MB, Onajin O, Sangüeza OP, McMichael A. Hypopigmented Macules as Manifestation of Lichen Planus and Lichen Planopilaris. Am J Dermatopathol. 2019 Jul; 41(7):514-517.Am J Dermatopathol2019-07-01T00:00:002019Hypopigmented Macules as Manifestation of Lichen Planus and Lichen Planopilaris.Internal Medicine, Cardiovascular Medicine24063352Feldman SR, Levi E, Pathak P, Kakatkar S, Balkrishnan RJournal of medical economicsFeldman SR, Levi E, Pathak P, Kakatkar S, Balkrishnan R. Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs. J Med Econ. 2013 Dec; 16(12):1405-13.J Med Econ2013-10-18T00:00:002013Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor23545912Feldman SR, Mills M, Brundage T, Eastman WJJournal of drugs in dermatology : JDDFeldman SR, Mills M, Brundage T, Eastman WJ. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp. J Drugs Dermatol. 2013 Mar; 12(3):300-6.J Drugs Dermatol2013-03-01T00:00:002013A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.2.353210.3047294research area of0.7237030.11270715subject area for